GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by James Thorne on Apr 17, 2019 at ...
Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. One of the most fundamental accessibility benefits of this ...
Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...
A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Charlotte Schubert on Nov 10, 2021 ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...
Near total lack of transparency. Almost no actionable info. Hawks their own expensive supplements. Expensive. On the surface, the Full Body Intelligence Test is the most thorough kit Viome sells. It ...
BELLEVUE, Wash., June 16, 2020 (GLOBE NEWSWIRE) -- Viome, a mission-driven systems biology company aiming to help individuals improve their health, has launched a world-first Health Intelligence ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that ...
Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health ...
Biotechnology company Viome Life Sciences will be expanding its development of direct-to-consumer diagnostic tests and wellness products after receiving $67 million in series C funding, the startup ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results